Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction

British Journal of Anaesthesia

Volumn 86, Issue 2, 2001, Pages 169-175

  Ryckwaert, F ^a   Colson, P ^a   Ribstein, J ^b   Boccara, G ^a   Guillon, G ^c  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c CCIPE   (France)

Author keywords

Hormones, antidiuretic, vasopressin; Kidney, function; Pharmacology, ACE inhibitors; Surgery, cardiovascular

Indexed keywords

ALDOSTERONE; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRILAT; FENTANYL; IODOHIPPURATE SODIUM I 131; MIDAZOLAM; NITRATE; PANCURONIUM; PHENYLEPHRINE; RENIN; RINGER SOLUTION; VASOPRESSIN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTIVE SURGERY; FEMALE; HEART INDEX; HEART OUTPUT; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY PERFUSION; KIDNEY PLASMA FLOW; MALE; OPEN HEART SURGERY; PLASMA RENIN ACTIVITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE;

EID: 0035141809     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/86.2.169     Document Type: Article

References (35)

1. Renal failure after open heart surgery
2. Etiology, incidence and prognosis of renal failure following cardiac operation
3. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization
4. Sequential pathophysiological changes characterizing the progression from renal dysfunction to acute renal failure following cardiac operation
5. Renal function in patients undergoing cardiopulmonary bypass operations
6. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery
7. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure
8. The role of the renin-angiotensin system in the renal and hormonal responses to tilt in normal man
9. Preoperative inhibition of angiotensin-converting enzyme improves systemic and renal haemodynamic changes during aortic abdominal surgery
10. Mechanism of action of angiotensin II and antidiuretic hormone on renin secretion
11. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements
12. Angiotensin-converting enzyme inhibitors
13. Influence of chronic angiotensin-converting enzyme inhibition on anaesthetic induction
14. Haemodynamic effect of anaesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors
15. Haemodynamic effects of anaesthesia in patients with ischaemic heart failure chronically treated with angiotensin-converting enzyme inhibitors
16. Effect of acute angiotensin inhibition on left ventricular filling in patients with congestive heart failure
17. Can clonidine, enoximone, and enalaprilat help to protect the myocardium against ischaemia in cardiac surgery?
18. Haemodynamic effects of vasopressin antagonism and angiotensin I converting enzyme inhibition during halothane anaesthesia in sheep
19. Endogenous vasopressin and renin angiotensin systems support blood pressure after epidural block in humans
20. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness
21. Intravenous captopril treatment in patients with severe cardiac failure
22. Intraoperative administration of the intravenous angiotensin-converting enzyme inhibitor, enalaprilat, in a patient with congestive heart failure
23. Enalaprilat decreases plasma endothelin and atrial natriuretic peptide levels and preload in patients with left ventricular dysfunction after cardiac surgery
24. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass
25. Long-term angiotensin converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering haemodynamic control in patients undergoing cardiac surgery
26. Renal haemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats
27. Anaesthesia affects plasma concentrations of vasopressin, von Willebrand factor and coagulation factor VIII in cardiac surgical patients
28. Haemodynamic and hormonal response to hypothermic and normothermic cardiopulmonary bypass
29. Plasma vasopressin levels and urinary flow during cardiopulmonary bypass in patients with valvular heart disease
30. Haemodynamically mediated acute renal failure
31. Coronary vasodilation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilizapril in patients with congestive heart failure
32. Effect of angiotensin-converting enzyme inhibitors on myocardial ischaemia-reperfusion injury: An overview
33. Influence of intravenous administration of angiotensin-converting inhibitor enalaprilat on cardiovascular mediators in cardiac surgery patients
34. Relationship between alteration in renal haemodynamics during cardiopulmonary bypass and postoperative renal function
35. Invalid determination of renal blood flow during hypothermic cardiopulmonary bypass